118 related articles for article (PubMed ID: 10695702)
1. Rationale and design of the Cardiac Hospitalization Atherosclerosis Management Program at the University of California Los Angeles.
Fonarow GC; Gawlinski A
Am J Cardiol; 2000 Feb; 85(3A):10A-17A. PubMed ID: 10695702
[TBL] [Abstract][Full Text] [Related]
2. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP).
Fonarow GC; Gawlinski A; Moughrabi S; Tillisch JH
Am J Cardiol; 2001 Apr; 87(7):819-22. PubMed ID: 11274933
[TBL] [Abstract][Full Text] [Related]
3. In-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes: the University of California-Los Angeles, Cardiovascular Hospitalization Atherosclerosis Management Program.
Fonarow GC; Gawlinski A; Watson K
Crit Pathw Cardiol; 2003 Jun; 2(2):61-70. PubMed ID: 18340322
[TBL] [Abstract][Full Text] [Related]
4. UCLA's coronary artery disease initiative begins at the hospital with medication, lifestyle interventions.
Clin Resour Manag; 2001 Jul; 2(7):109-11. PubMed ID: 11482249
[TBL] [Abstract][Full Text] [Related]
5. CAD initiative begins at the hospital with medication, lifestyle interventions.
Clin Resour Manag; 2001 Sep; 2(9):132-5, 129. PubMed ID: 11577511
[TBL] [Abstract][Full Text] [Related]
6. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
7. Cardiac medical therapy among patients undergoing abdominal aortic aneurysm repair.
Kurzencwyg D; Filion KB; Pilote L; Nault P; Platt RW; Rahme E; Steinmetz O; Eisenberg MJ
Ann Vasc Surg; 2006 Sep; 20(5):569-76. PubMed ID: 16794911
[TBL] [Abstract][Full Text] [Related]
8. Use of perioperative cardiac medical therapy among patients undergoing coronary artery bypass graft surgery.
Filion KB; Pilote L; Rahme E; Eisenberg MJ
J Card Surg; 2008; 23(3):209-15. PubMed ID: 18435634
[TBL] [Abstract][Full Text] [Related]
9. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
[TBL] [Abstract][Full Text] [Related]
10. Statin initiation following coronary artery bypass grafting: outcome of a hospital discharge protocol.
Khanderia U; Townsend KA; Eagle K; Prager R
Chest; 2005 Feb; 127(2):455-63. PubMed ID: 15705982
[TBL] [Abstract][Full Text] [Related]
11. Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes.
Gencer B; Rodondi N; Auer R; Räber L; Klingenberg R; Nanchen D; Carballo D; Vogt P; Carballo S; Meyer P; Matter CM; Windecker S; Lüscher TF; Mach F
Eur J Intern Med; 2015 Jan; 26(1):56-62. PubMed ID: 25582072
[TBL] [Abstract][Full Text] [Related]
12. Hospital revascularisation capability and quality of care after an acute coronary syndrome in Switzerland.
Welker J; Auer R; Gencer B; Muller O; Cornuz J; Matter CM; Mach F; Windecker S; Rodondi N; Nanchen D
Swiss Med Wkly; 2016; 146():w14275. PubMed ID: 26859223
[TBL] [Abstract][Full Text] [Related]
13. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS].
Yahia DH; Pereg D; Lishner M; Elis A
Harefuah; 2015 May; 154(5):299-302, 339-40. PubMed ID: 26168639
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
[TBL] [Abstract][Full Text] [Related]
15. Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial.
Goff DC; Gu L; Cantley LK; Sheedy DJ; Cohen SJ
Am Heart J; 2003 Dec; 146(6):1045-51. PubMed ID: 14660997
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
[TBL] [Abstract][Full Text] [Related]
17. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
18. Mapping geographic areas of high and low drug adherence in patients prescribed continuing treatment for acute coronary syndrome after discharge.
Hoang C; Kolenic G; Kline-Rogers E; Eagle KA; Erickson SR
Pharmacotherapy; 2011 Oct; 31(10):927-33. PubMed ID: 21950639
[TBL] [Abstract][Full Text] [Related]
19. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of hospitalization period and five-year follow-up of patients admitted with acute coronary syndrome following coronary artery bypass graft surgery].
Can LH; Kayıkçıoğlu M; Yavuzgil O; Kültürsay H; Soydan I
Turk Kardiyol Dern Ars; 2010 Sep; 38(6):387-92. PubMed ID: 21200116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
